A detailed history of Pine Bridge Investments, L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Pine Bridge Investments, L.P. holds 404,267 shares of PFE stock, worth $11.8 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
404,267
Previous 613,261 34.08%
Holding current value
$11.8 Million
Previous $17 Million 33.53%
% of portfolio
0.09%
Previous 0.14%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $5.28 Million - $6.19 Million
-208,994 Reduced 34.08%
404,267 $11.3 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $3.68 Million - $4.23 Million
142,318 Added 30.22%
613,261 $17 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $33.6 Million - $43.6 Million
-1,284,612 Reduced 73.17%
470,943 $13.6 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $9.82 Million - $11.5 Million
306,147 Added 21.12%
1,755,555 $58.2 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $5 Million - $5.79 Million
-138,514 Reduced 8.72%
1,449,408 $53.2 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $1.91 Million - $2.49 Million
48,475 Added 3.15%
1,587,922 $64.8 Million
Q4 2022

Feb 09, 2023

BUY
$41.75 - $54.5 $1.47 Million - $1.92 Million
35,143 Added 2.34%
1,539,447 $78.9 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $10.5 Million - $12.8 Million
239,579 Added 18.94%
1,504,304 $65.8 Million
Q2 2022

Aug 05, 2022

BUY
$46.53 - $55.17 $10.5 Million - $12.4 Million
224,751 Added 21.61%
1,264,725 $66.3 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $23.2 Million - $28.8 Million
507,327 Added 95.25%
1,039,974 $53.8 Million
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $2.13 Million - $3.16 Million
-51,662 Reduced 8.84%
532,647 $31.5 Million
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $1.46 Million - $1.88 Million
37,274 Added 6.81%
584,309 $25.1 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $6.95 Million - $7.87 Million
-193,539 Reduced 26.13%
547,035 $21.4 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $10.4 Million - $11.8 Million
311,826 Added 72.73%
740,574 $26.8 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $26.2 Million - $33.3 Million
-782,435 Reduced 64.6%
428,748 $15.8 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $6.49 Million - $7.61 Million
204,313 Added 20.29%
1,211,183 $44.5 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $510,021 - $618,731
16,933 Added 1.71%
1,006,870 $32.9 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $487,837 - $697,013
-18,048 Reduced 1.79%
989,937 $32.3 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $563,820 - $639,864
-17,127 Reduced 1.67%
1,007,985 $39.5 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $4 Million - $5.19 Million
-123,243 Reduced 10.73%
1,025,112 $36.8 Million
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $22.7 Million - $25.5 Million
614,366 Added 115.05%
1,148,355 $49.7 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $810,600 - $890,579
21,616 Added 4.22%
533,989 $22.7 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $1.39 Million - $1.58 Million
36,088 Added 7.58%
512,373 $22.4 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $1.83 Million - $2.22 Million
-52,996 Reduced 10.01%
476,285 $21 Million
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $10.2 Million - $10.8 Million
307,823 Added 139.0%
529,281 $19.2 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $777,965 - $902,547
-24,380 Reduced 9.92%
221,458 $7.86 Million
Q4 2017

Feb 09, 2018

SELL
$33.26 - $35.29 $2.44 Million - $2.59 Million
-73,464 Reduced 23.01%
245,838 $8.91 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $2.05 Million - $2.26 Million
66,076 Added 26.09%
319,302 $11.4 Million
Q2 2017

Aug 11, 2017

BUY
N/A
253,226
253,226 $8.51 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Pine Bridge Investments, L.P. Portfolio

Follow Pine Bridge Investments, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.